Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Brain Stimulation Shown to Reduce Insulin Resistance

brain stimulationgraphic

Electrical stimulation of an area in the brain that releases the hormone dopamine is shown to increase sensitivity to insulin, opening a potential new pathway for treating type 2 diabetes. . . . → Read More: Brain Stimulation Shown to Reduce Insulin Resistance

Trial Testing Gene-Edited, Modified Oilseed Plants

Camelina plant

An agricultural science lab in the U.K. is beginning research on sustainable methods for growing genome-edited camelina plants, along with modifying the plant’s genetics by adding genes from other plant species. . . . → Read More: Trial Testing Gene-Edited, Modified Oilseed Plants

Cannabis Derivative Shown to Reduce Severe Seizures

Epilepsy graphic

A clinical trial shows treatments made with cannabidiol, a medical-grade derivative of cannabis plants, reduce the number of severe seizures in people with Lennox–Gastaut syndrome, when combined with conventional drugs. . . . → Read More: Cannabis Derivative Shown to Reduce Severe Seizures

Computer-Designed Heart Valves Operate Over Long Term

Engineered heart valve

A European research team designed customized heart valves with computer models, which when tested in sheep continued to perform in most cases for a year following implantation. . . . → Read More: Computer-Designed Heart Valves Operate Over Long Term

Virtual Reality Harnessed for Stroke Rehab

Peii Chen

A rehabilitation research foundation and company specializing in immersive technologies are applying virtual reality to help treat spacial neglect, a common cognitive disability associated with stroke. . . . → Read More: Virtual Reality Harnessed for Stroke Rehab

Gene Therapy Biotech Acquired in $8.7 Billion Deal

A biotechnology enterprise developing gene therapies for rare inherited diseases and neurological disorders is being acquired by pharmaceutical company Novartis AG for $8.7 billion. . . . → Read More: Gene Therapy Biotech Acquired in $8.7 Billion Deal

Drug Shown Able to Kill Malaria-Carrier Mosquitoes

A clinical trial in Kenya shows blood from people who take a current anti-parasite drug can kill mosquitoes carrying malaria, offering a potential new strategy for controlling this disease. . . . → Read More: Drug Shown Able to Kill Malaria-Carrier Mosquitoes

Immune Disease Precision Therapy Company Starts Up

An enterprise to discover biomarkers and precise treatments for individuals with immune system disorders is starting up, founded by six researchers in the U.S. and Europe. . . . → Read More: Immune Disease Precision Therapy Company Starts Up

Novartis Licenses Biomaterial for Cancer Immunotherapy

Drug maker Novartis is licensing from a lab at Harvard University a biocompatible material designed to provide delivery of treatments that invoke the immune system to fight cancer. . . . → Read More: Novartis Licenses Biomaterial for Cancer Immunotherapy

More Accurate Thyroid Cancer Screening Technology Advances

A European initiative is developing a laser-enhanced technology to better distinguish between cancerous and benign thyroid nodules, for catching thyroid cancer earlier as well as preventing unnecessary surgeries. . . . → Read More: More Accurate Thyroid Cancer Screening Technology Advances